Gangliosidoses clinical trials at UCSF
1 research study open to eligible people
Gangliosidoses are rare inherited diseases that cause harmful fat to build up in brain and nerve cells. UCSF is running studies that collect medical histories and biological samples from people with these disorders. UCSF is storing and analyzing these data and samples to support research on rare brain diseases.
Myelin Disorders Biorepository Project
open to all eligible people
The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, having enrolled nearly 2,000 affected individuals since it was launched over a decade ago. Researchers working in the biorepository hope to use these materials to uncover new genetic etiologies for various leukodystrophies, develop biomarkers for use in future clinical trials, and better understand the natural history of these disorders. The knowledge gained from these efforts may help improve the diagnostic tools and treatment options available to patients in the future.
San Francisco, California and other locations
Last updated: